{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:39:09Z","timestamp":1792402749865,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005198.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T00:00:00Z","timestamp":1309910400000}}],"reference-count":84,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005198.pub3","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T20:33:14Z","timestamp":1309811594000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic interventions for Burkitt lymphoma in children"],"prefix":"10.1002","author":[{"given":"Joseph U","family":"Okebe","sequence":"first","affiliation":[{"name":"Medical Research Council Unit; P.O. Box 273 Banjul Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Skoetz","sequence":"additional","affiliation":[{"name":"University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin M","family":"Meremikwu","sequence":"additional","affiliation":[{"name":"University of Calabar Teaching Hospital; Department of Paediatrics; PMB 1115 Calabar Cross River State Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Richards","sequence":"additional","affiliation":[{"name":"Oxford University; Clinical Trials Services Unit; Woodstock Road Oxford UK OX2 6HE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,6]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD005198.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198303103081003","article-title":"Childhood non-Hodgkin's lymphoma. The results of a randomised therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)","volume":"308","author":"Anderson","year":"1983","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/(SICI)1096-911X(199712)29:6<526::AID-MPO2>3.0.CO;2-M","article-title":"Fractionated cyclophosphamide and back to back high dose methrotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (snccl): a randomised trial of the pediatric oncology group","volume":"29","author":"Brecher","year":"1997","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0003|cit3","unstructured":"Cairo MS Gerrard M Sposto R Auperin A Pinkerton R Michon J Results of a randomised FAB LMB89 international study in children and adolescents (C+A) with advanced (bone marrow [BM] [B-ALL] and\/or CNS) B-NHL (large cell [LCL], Burkitt's [BM] and Burkitt-like [BLL]): Pts with L3 leukemia\/ CNS- have an excellent prognosis Procdeedings of the American society of Clinical Oncology 2003 796"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0004|cit4","first-page":"67","article-title":"Prophylaxis of meningeal Burkitt's lymphoma with CCNU","volume":"14","author":"Magrath","year":"1973","journal-title":"American Association for Cancer Research"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0006|cit5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/bmj.1.6010.615","article-title":"Failure of BCG immunostimulation to affect the clinical course of Burkitt's Lymphoma","volume":"1","author":"Magrath","year":"1976","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0005|cit6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-3-642-49284-6_67","article-title":"Preliminary results of a randomized trial of BCG immunotherapy in Burkitt's lymphoma","volume":"47","author":"Magrath","year":"1974","journal-title":"Recent Results in Cancer Research"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0008|cit7","first-page":"199","article-title":"BCG immunotherapy in Burkitt's lymphoma: preliminary results of a randomized clinical trial","volume":"39","author":"Ziegler","year":"1973","journal-title":"National Cancer Institute Monograph"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0007|cit8","unstructured":"Ziegler JL Magrath IT Bluming AZ BCG immunotherapy of Burkitt's lymphoma Proceedings of the American Association for Cancer Research 1972 38"},{"issue":"5A","key":"10.1002\/14651858.CD005198.pub3-BIB0009|cit9","first-page":"1183","article-title":"Specific transfer factor with activity against Ebstein-Barr virus reduces late relapse in endemic Burkitt's lymphoma","volume":"10","author":"Neequaye","year":"1990","journal-title":"Anticancer Research"},{"issue":"4","key":"10.1002\/14651858.CD005198.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ijc.2910170404","article-title":"Treatment of Burkitt's lymphoma: randomized clinical trial of single-agent versus combination chemotherapy","volume":"17","author":"Olweny","year":"1976","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub3-BIB0011|cit11","first-page":"225","article-title":"Cerebrospinal irradiation of Burkitt's lymphoma","volume":"16","author":"Olweny","year":"1977","journal-title":"Acta Radiologica: Oncology, Radiation, Physics, Biology"},{"issue":"1","key":"10.1002\/14651858.CD005198.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","article-title":"High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French pediatric oncology society of a randomized trial of 216 children","volume":"9","author":"Patte","year":"1991","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD005198.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00043426-199123000-00007","article-title":"High-dose Cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a pediatric oncology group study","volume":"13","author":"Sullivan","year":"1991","journal-title":"The American Journal of Pediatric Hematology\/Oncology"},{"issue":"773","key":"10.1002\/14651858.CD005198.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bmj.3.5773.508","article-title":"Intrathecal chemotherapy in Burkitt's lymphoma","volume":"3","author":"Ziegler","year":"1971","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD005198.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ijc.2910100205","article-title":"Intensive chemotherapy in patients with generalized Burkitt's lymphoma","volume":"10","author":"Ziegler","year":"1972","journal-title":"International Journal of Cancer"},{"issue":"2 suppl 4","key":"10.1002\/14651858.CD005198.pub3-BIB0017|cit17","first-page":"33","article-title":"Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas","volume":"25","author":"Adde","year":"1998","journal-title":"Seminars in Oncology"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1182\/blood-2008-06-162289","article-title":"Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone","volume":"112","author":"Amengual","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0964-1955(96)00031-0","article-title":"Marginal zone B cell lymphoma of the parotid glands","volume":"32B","author":"Aviles","year":"1996","journal-title":"European Journal of Cancer part B, Oral Oncology"},{"issue":"1-2","key":"10.1002\/14651858.CD005198.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000089460","article-title":"Frontline therapy with early intensification and autologous stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non-Hodgkin's lymphoma patients: a prospective randomized GEMOH report","volume":"115","author":"Baldissera","year":"2006","journal-title":"Acta Haematologica"},{"issue":"12","key":"10.1002\/14651858.CD005198.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/cncr.22344","article-title":"Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153","volume":"107","author":"Blum","year":"2006","journal-title":"Cancer"},{"issue":"25","key":"10.1002\/14651858.CD005198.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1200\/JCO.2005.05.4684","article-title":"Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma","volume":"24","author":"Bou\u00e9","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD005198.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","article-title":"Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents","volume":"109","author":"Cairo","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD005198.pub3-BIB0024|cit24","first-page":"45","article-title":"Peripheral T-cell lymphocytes have a poorer prognosis than B-cell lymphomas: A prospective study of 361 immunotyped patients treated with LNH-84 regimen","volume":"1","author":"Coiffier","year":"1990","journal-title":"Journal of the European Society for Medical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD005198.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PPO.0b013e3181570170","article-title":"CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group","volume":"13","author":"Economopoulos","year":"2007","journal-title":"Cancer Journal"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MPH.0b013e31819a5d58","article-title":"Burkitt lymphoma in children: the Israeli experience","volume":"31","author":"Eldar","year":"2009","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-0609.2005.00609.x","article-title":"The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study","volume":"76","author":"Federico","year":"2006","journal-title":"European Journal of Haematology"},{"issue":"12","key":"10.1002\/14651858.CD005198.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/jcp.2007.051953","article-title":"HIV infection and lymphoma","volume":"60","author":"Grogg","year":"2007","journal-title":"Journal of Clinical Pathology"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2000.18.10.2017","article-title":"Outcome of CNS disease at diagnosis in disseminated small non-cleaved cell lymphoma and B-cell leukaemia: a children's cancer group study","volume":"18","author":"Gururagan","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1200\/JCO.2005.03.7952","article-title":"Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma","volume":"24","author":"Hagenbeek","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1200\/JCO.2005.12.191","article-title":"Maximising therapeutic effect of rituximab: maintenance treatment vs. re-treatment at progression in patients with indolent non-Hodgkin's lymphoma- a randomized phase two trial of the Minie Pearl research network","volume":"23","author":"Hainsworth","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0032|cit32","unstructured":"Haioun C Lepage E Gisselbrecht C Coiffier B Bosly A Tilly H Comparison of autologous bone marrow transplantation (BMT) with sequential chemotherapy for aggressive non-Hodgkin's lymphoma in first remission: a study on 464 patients (LNH 87 protocol) 5th International Conference on Malignant Lymphoma 1993 85a"},{"issue":"1","key":"10.1002\/14651858.CD005198.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1179\/146532809X402006","article-title":"Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate","volume":"29","author":"Hesseling","year":"2009","journal-title":"Annals of Tropical Paediatrics"},{"issue":"9","key":"10.1002\/14651858.CD005198.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V89.9.3129","article-title":"Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma- long term results of a clinical trial","volume":"89","author":"Hsu","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1200\/JCO.1991.9.6.929","article-title":"Clinical and virologic effects of recombinant human-granulocyte colony stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial","volume":"9","author":"Kaplan","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0036|cit36","unstructured":"Kimby E Mellstedt H Chlorambucil\/prednisolone (CHP) versus CHOP in symptomatic low grade lymphomas 5th International Conference on Malignant Lymphoma 1993"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1200\/JCO.2005.11.075","article-title":"Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial","volume":"23","author":"Laver","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD005198.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jama.1991.03470010088036","article-title":"Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS- related lymphoma","volume":"266","author":"Levine","year":"1991","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD005198.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/CCO.0b013e32832f3dcd","article-title":"Lessons from clinical trials in African Burkitt lymphoma","volume":"21","author":"Magrath","year":"2009","journal-title":"Current Opinions in Oncology"},{"issue":"8","key":"10.1002\/14651858.CD005198.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1182\/blood.V84.8.2457.2457","article-title":"Phase I clinical trial using escalating single-dose infusion of chimeric Anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma","volume":"84","author":"Maloney","year":"1994","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1200\/JCO.1997.15.10.3266","article-title":"IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma","volume":"15","author":"Maloney","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub3-BIB0042|cit42","first-page":"585","article-title":"Treatment of histiocytic lymphoma in Ugandan adults","volume":"48","author":"Olweny","year":"1971","journal-title":"East African Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD005198.pub3-BIB0043|cit43","first-page":"990","article-title":"Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3\/97 study","volume":"90","author":"Oriol","year":"2005","journal-title":"Haematologica"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2003-06-2094","article-title":"Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSNHL","volume":"104","author":"Pfreundschuh","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/annonc\/mdm514","article-title":"Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)","volume":"19","author":"Pfreundschuh","year":"2008","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1002\/14651858.CD005198.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2008-1046608","article-title":"NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 1: classification and allocation to strategic therapy groups. BIF study group","volume":"206","author":"Reiter","year":"1994","journal-title":"Klinische P\u00e4diatrie"},{"issue":"4","key":"10.1002\/14651858.CD005198.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-2008-1046610","article-title":"NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: an intermediate term analysis of the B-NHL\/B-ALL.","volume":"204","author":"Reiter","year":"1994","journal-title":"Klinische P\u00e4diatrie"},{"issue":"5","key":"10.1002\/14651858.CD005198.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/CCO.0b013e3282c8c835","article-title":"HIV-associated lymphoma: the evidence for treating aggressively but with caution","volume":"19","author":"Sparano","year":"2007","journal-title":"Current Opinions in Oncology"},{"issue":"5","key":"10.1002\/14651858.CD005198.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.cco.0000172824.78318.b9","article-title":"Rituximab for HIV-associated lymphoma: weighing the benefits and risks","volume":"17","author":"Spina","year":"2005","journal-title":"Current Opinions in Oncology"},{"issue":"5","key":"10.1002\/14651858.CD005198.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0609.2006.00735.x","article-title":"Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-M\u00fcnster-90 protocol","volume":"77","author":"Sun","year":"2006","journal-title":"European Journal of Haematology"},{"issue":"6","key":"10.1002\/14651858.CD005198.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1200\/JCO.2000.18.6.1309","article-title":"Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study","volume":"18","author":"Tilly","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD005198.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00432-003-0508-9","article-title":"Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study","volume":"130","author":"Tsurumi","year":"2004","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"(suppl 1)","key":"10.1002\/14651858.CD005198.pub3-BIB0053|cit53","first-page":"74","article-title":"MACOP-B vs. MACHOP in the treatment of high-grade non-Hodgkin's lymphoma","volume":"5","author":"Tura","year":"1991","journal-title":"Leukemia"},{"issue":"7","key":"10.1002\/14651858.CD005198.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood-2006-07-035709","article-title":"Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)","volume":"109","author":"Verdonck","year":"2007","journal-title":"Blood"},{"issue":"suppl 12","key":"10.1002\/14651858.CD005198.pub3-BIB0055|cit55","first-page":"74","article-title":"The use of Ibritumomab tiuxetan radioimmunology for patients with relapsed B-cell non-Hodgkin's lymphoma","volume":"27","author":"Witzig","year":"2000","journal-title":"Seminars in Oncology"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1200\/JCO.2002.11.076","article-title":"Randomized controlled trial of Yttrium-90-labeled Ibritumomab Tiuxetan radioimmunotherapy versus Rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma","volume":"20","author":"Witzig","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"11-12","key":"10.1002\/14651858.CD005198.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.cr.7290372","article-title":"AIDS and associated malignancies","volume":"15","author":"Wood","year":"2005","journal-title":"Cell Research"},{"issue":"4","key":"10.1002\/14651858.CD005198.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11523-010-0161-6","article-title":"Use of rituximab in three children with relapsed\/refractory Burkitt lymphoma","volume":"5","author":"Akbayram","year":"2010","journal-title":"Targeted Oncology"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0165-4608(81)90039-X","article-title":"Cytogenic studies on African Burkitt's lymphoma cell lines; t(8;14),t(2;8), and t(8;22) translocations","volume":"3","author":"Bernheim","year":"1981","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"Sarcoma involving jaws in African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2003.04134.x","article-title":"Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.","volume":"4","author":"Cairo","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/tropej\/36.3.114","article-title":"Burkitt's lymphoma and the role of Ebstein- Barr virus","volume":"30","author":"Goldstein","year":"1990","journal-title":"Journal of Tropical Paediatrics"},{"issue":"2","key":"10.1002\/14651858.CD005198.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/modpathol.3880035","article-title":"The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia,November 1997","volume":"13","author":"Harris","year":"2000","journal-title":"Modern Pathology"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0065|cit65","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 The Cochrane Collaboration"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00001622-200409000-00003","article-title":"Treatment advances in adult Burkitt lymphoma and leukemia","volume":"16","author":"Kasamon","year":"2004","journal-title":"Current Opinions in Oncology"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0889-8588(03)00050-9","article-title":"Etiology and pathogenesis of AIDS-related non-Hodgkin\u2019slymphoma","volume":"17","author":"Knowles","year":"2003","journal-title":"Hematology\/Oncology Clinics of North America"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0068|cit68","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch6","article-title":"Chapter 6:Searching for studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Lefebre","year":"2008"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-3-642-49284-6_67","article-title":"Preliminary results of a randomized trial of BCG immunotherapy in Burkitt's lymphoma.","volume":"47","author":"Magrath","year":"1974","journal-title":"Recent results in cancer research"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/bmj.2.5914.308","article-title":"Surgical reduction of tumor bulk in management of abdominal Burkitt's Lymphoma","volume":"2","author":"Magrath","year":"1974","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0889-8588(18)30642-7","article-title":"Malignant non-Hodgkin's lymphomas in children","volume":"1(4)","author":"Magrath","year":"1987","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"11","key":"10.1002\/14651858.CD005198.pub3-BIB0072|cit72","first-page":"41","article-title":"Biology and treatment of small non-cleaved cell lymphoma. Biology and treatment of small non-cleaved cell lymphoma. Biology and treatment of small non-cleaved cell lymphoma","volume":"3","author":"Magrath","year":"1989","journal-title":"Oncology"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00001622-200209000-00009","article-title":"B-cell activation and lymphoma in patients with HIV","volume":"14","author":"Martinez-Maza","year":"2002","journal-title":"Current Opinions in Oncology"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0074|cit74","doi-asserted-by":"crossref","unstructured":"Meremikwu MM Ehiri JE Nkanga DG Udoh EE Ikpatt OF Alaje EO Socio-economic constraints to effective management of Burkitt's lymphoma in south-east Nigeria Tropical Medicine and International Health 2005 (in press)","DOI":"10.1111\/j.1365-3156.2004.01348.x"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0075|cit75","first-page":"545","article-title":"Conventional and superfractionated radiation therapy in Burkit's lymphoma","volume":"10","author":"Norlin","year":"1971","journal-title":"Acta Radiologica"},{"issue":"4","key":"10.1002\/14651858.CD005198.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1179\/027249302125002038","article-title":"Epidemiology of Burkitt's lymphoma in Enugu, Nigeria","volume":"22","author":"Oguonu","year":"2002","journal-title":"Annals of Tropical Paediatrics"},{"issue":"3","key":"10.1002\/14651858.CD005198.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ijc.2910260302","article-title":"Long-term experience with Burkitt's lymphoma in Uganda","volume":"26","author":"Olweny","year":"1980","journal-title":"International Journal of Cancer"},{"issue":"24","key":"10.1002\/14651858.CD005198.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD005198.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/annonc\/mdh262","article-title":"Treatment of Burkitt's\/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens.","volume":"15","author":"Smeland","year":"2004","journal-title":"Annals of Oncology"},{"issue":"10","key":"10.1002\/14651858.CD005198.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1158\/0008-5472.CAN-04-0079","article-title":"Steps involved in immortalization and tumorigenesis of human b-lymphoblastoid cell lines transformed by Epstein-Barr virus","volume":"64","author":"Sugimoto","year":"2004","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/1097-0142(197212)30:6<1534::AID-CNCR2820300619>3.0.CO;2-6","article-title":"Chemotherapy of Burkitt's lymphoma","volume":"30","author":"Ziegler","year":"1972","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0082|cit82","volume-title":"Pathology Annual","author":"Ziegler","year":"1974"},{"key":"10.1002\/14651858.CD005198.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM198109243051305","article-title":"Burkitt's Lymphoma","volume":"305","author":"Ziegler","year":"1981","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005198.pub3-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005198.pub2","article-title":"Therapeutic interventions for Burkitt's lymphoma in children","author":"Okebe","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005198.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:46:20Z","timestamp":1628545580000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005198.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,6]]},"references-count":84,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005198.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,6]]}}}